Verwendung eines Leukämie-hemmenden Faktor Antagonisten

摘要

A leukemia inhibitory factor antagonist, along or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.